Perrigo Company plc

Perrigo Company plc

PRGO

$14.31

Updated: 23/09/2026, 11:11:24

Market Cap
$1.98B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
IE
Stock valuation chart
One-year closing share-price history for PRGO
Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

USD
NYSE
CEO: Albert A. Manzone
Employees: 8,100
https://www.perrigo.com
Asset Summaries
Latest generated summaries for PRGO

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for PRGO.
Share price
$14.31
Market cap
$1.98B
Exchange
NYSE
Currency
USD
CEO
Albert A. Manzone
Employees
8,100
IPO date
17/12/1991
Beta
0.536
Last dividend
$0.00
Day range
$14.16 – $14.45
52-week range
$9.23 – $22.65
1-day performance
1.27%
1-year performance
55.04%
Current drawdown (1Y)
-36.82%
CIK
0001585364
CUSIP
N/A
ISIN
IE00BGH1M568
Created
07/12/2025, 13:46:59
Last update
23/09/2026, 11:11:24

Track Perrigo Company plc with an AI analyst

See which prediction-market events move PRGO, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.